Advertisement

Topics

Orion Bionetworks Company Profile

10:00 EST 10th December 2018 | BioPortfolio


News Articles [80 Associated News Articles listed on BioPortfolio]

Sage Bionetworks Launches Digital Health Catalyst Program

David RathsSage Bionetworks is launching a program to provide pro bono support innovative ideas for biomedical research studies that leverage smartphones, wearables and sensors.

Orion Corporation: Licenses and Growth for Mid-size Companies in Europe

In this episode of PharmaTelevision News Review, Fintan Walton talks with Jukka Muhonen at Orion Corporation. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • Orion's origins a...

M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners

Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum. K2Biomedical will operate as Orion Biotechnology Poland,...Read More... The post M&As this week: O...

Orion divests Orion Diagnostica division to PE firm Axcel for up to €223mm

An investment fund managed by Nordic private equity investment company Axcel Management AS agreed to acquire Orion Diagnostica Oy (point-of-care testing instruments and kits) for a fixed price of €1...

Bayer, Orion drug shown to delay spread of prostate cancer

German drugmaker Bayer and Finland's Orion said on Wednesday a study showed a prostate cancer drug they are jointly developing can delay the spread of the disease to other parts of the body, boosting ...

MTBC Successfully Closes Orion, Largest Acquisition to Date

Company Acquires Assets of Orion Healthcorp, Inc. and its 13 Affiliates SOMERSET, N.J.,, July 02, 2018 (GLOBE NEWSWIRE) Read more...

Orion Health Selling its Rhapsody Platform for $205 Million

David RathsNew Zealand-based Orion Health Group announced that it will sell its Rhapsody business unit for $205 million to private equity firm Hg. The U.K.-based firm will also take a quarter stake in...

Orion enrols first patient in REFALS trial of levosimendan

Orion has enrolled the first patient in the REFALS trial, a Phase III clinical study of levosimendan (ODM-109) for the...Read More... The post Orion enrols first patient in REFALS trial of levosimenda...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

The Safety and Accuracy of the RHYTHMIA Mapping System in Pediatric Patients.

A new mapping system (Rhythmia) using a 64 mini-electrode small basket array (Orion) was developed and enables rapid high-density mapping in a short time. However, there are few reports about the usef...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Early Feasibility Study of the Orion Visual Cortical Prosthesis System

This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perce...

Prospective Registry on User Experience With The Mapping System For Ablation Procedures

This is an observational, prospective, non-randomized, multicenter, post approval study being conducted in the United States, Europe and Asia-Pacific Regions.

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagon...

ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)

This is an explorative, open-label, uncontrolled, single center study to explore the preliminary safety, tolerability and efficacy of oral ferric maltol in treating iron deficiency in pati...

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

The ORION study is being conducted to determine whether the Epic™ Nitinol Stent for primary stenting of iliac atherosclerotic lesions shows acceptable performance at 9 months.

Companies [23 Associated Companies listed on BioPortfolio]

Orion Research LLC

Orion Research LLC provides investigative research on public companies and was hired by Pershing Square Capital Management, L.P. to gather information on Herbalife and its Nutriti...

Orion Energy Systems, Inc.

Orion is leading the transformation of commercial and industrial buildings with state-of-the-art energy efficient lighting systems and retrofit lighting solutions. Orion manufactu...

Orion Health, Inc.

Orion Health™ is the leading Health Information Exchange (HIE) solution provider with expertise in clinical workflow and integration technology for the healthcare sector. Ori...

Orion Therapeutics, LLC

Orion Therapeutics is a Troy, Michigan-based biotech company with a mission to discover, develop and commercialize novel products derived from neutraceutical and food supplement m...

Orion Diagnostica Oy

Orion Diagnostica Oy is a biomedical company belonging to the Orion Group, the leading health-care company in Finland. Established in 1974, Orion Diagnostica specialises in rapid and easy-to-use clini...

More Information about "Orion Bionetworks" on BioPortfolio

We have published hundreds of Orion Bionetworks news stories on BioPortfolio along with dozens of Orion Bionetworks Clinical Trials and PubMed Articles about Orion Bionetworks for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orion Bionetworks Companies in our database. You can also find out about relevant Orion Bionetworks Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record